Figure 5.
Mean plasma concentration–time profile of triptolide (n=6). (A) After i.g. administration at a single dose of 0.4 mg/kg triptolide solution; (B) After transdermal delivery of TP-LHP with 1.6 mg/kg of triptolide under microneedles.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.